Real‐world effectiveness and drug survival of guselkumab over a period of 3 years in moderate‐to‐severe plaque psoriasis, including difficult‐to‐treat areas
Saved in:
| Published in | International journal of dermatology Vol. 63; no. 10; pp. e255 - e258 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
01.10.2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0011-9059 1365-4632 1365-4632 |
| DOI | 10.1111/ijd.17400 |
Cover
| Author | Befon, Angeliki Papoutsaki, Marina Rompoti, Natalia Koumprentziotis, Ioannis‐Alexios Nicolaidou, Electra Vavouli, Charitomeni Politou, Maria Zaimi, Maria Panagakis, Pantelis Kousta, Fiori Vergou, Theognosia Lazou, Eleni Stefanaki, Irene Chasapi, Vasiliki Stratigos, Alexander |
|---|---|
| Author_xml | – sequence: 1 givenname: Natalia orcidid: 0000-0002-9326-6726 surname: Rompoti fullname: Rompoti, Natalia email: natalia.rompoti@gmail.com organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 2 givenname: Theognosia surname: Vergou fullname: Vergou, Theognosia organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 3 givenname: Irene surname: Stefanaki fullname: Stefanaki, Irene organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 4 givenname: Charitomeni surname: Vavouli fullname: Vavouli, Charitomeni organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 5 givenname: Ioannis‐Alexios surname: Koumprentziotis fullname: Koumprentziotis, Ioannis‐Alexios organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 6 givenname: Pantelis surname: Panagakis fullname: Panagakis, Pantelis organization: “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 7 givenname: Marina surname: Papoutsaki fullname: Papoutsaki, Marina organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 8 givenname: Maria surname: Politou fullname: Politou, Maria organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 9 givenname: Angeliki surname: Befon fullname: Befon, Angeliki organization: “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 10 givenname: Fiori surname: Kousta fullname: Kousta, Fiori organization: “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 11 givenname: Eleni surname: Lazou fullname: Lazou, Eleni organization: “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 12 givenname: Maria surname: Zaimi fullname: Zaimi, Maria organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 13 givenname: Vasiliki surname: Chasapi fullname: Chasapi, Vasiliki organization: “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 14 givenname: Alexander surname: Stratigos fullname: Stratigos, Alexander organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases – sequence: 15 givenname: Electra surname: Nicolaidou fullname: Nicolaidou, Electra organization: Medical School, National and Kapodistrian University of Athens, “A. Sygros” Hospital for Skin and Venereal Diseases |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39051109$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc9uVCEYxYmpsdPqwhcwLDXxtjAw98_StGprmpgYXZPvwseEyr2MwJ1mdt268zF8rj5JGWdmY5TF-QL8zgnhnJCjMYxIyEvOznhZ5-7WnPFGMvaEzLioF5WsxfyIzBjjvOrYojsmJyndlq2Yc_mMHItyyDnrZuT3FwT_cP_rLkRvKFqLOrs1jpgShdFQE6clTVNcuzV4GixdTgn992mAnoY1Rgp0hdEFs70TD_c_NwgxUTfSIRiMkLGE51AkYcGRrjz8mMpIITpILr0trPaTceOSGmet05PPB0-OCJlC0fScPLXgE77Yz1Py7cP7rxdX1c3nj9cX724qLWrGKs5b7MAUqYXVRjZtDY2dt5YjlyCxbxcau3nHZdNIWeuFqXnfd1Y3ukfTM3FKXu9yVzGUh6asBpc0eg8jhikpwdpiFUJu0Vd7dOoHNGoV3QBxow6_W4DzHaBjSCmiVdplyC6MOYLzijO17U-V_tSf_orjzV-OQ-i_2H36nfO4-T-orj9d7hyP9DOzMg |
| CitedBy_id | crossref_primary_10_1111_ijd_17466 |
| Cites_doi | 10.1111/bjd.20568 10.1080/14712598.2023.2194485 10.1111/jdv.19296 10.1111/dth.13964 10.1007/s13555‐023‐00893‐4 |
| ContentType | Journal Article |
| Copyright | 2024 the International Society of Dermatology. |
| Copyright_xml | – notice: 2024 the International Society of Dermatology. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1111/ijd.17400 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1365-4632 |
| EndPage | e258 |
| ExternalDocumentID | 39051109 10_1111_ijd_17400 IJD17400 |
| Genre | correspondence Letter Correspondence |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29J 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AAQQT AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c3600-118e9ad8e963fcd4786a7f28f1e14a4eb85ce9291477446c5d61bb9fc7cbedb03 |
| IEDL.DBID | DR2 |
| ISSN | 0011-9059 1365-4632 |
| IngestDate | Thu Jul 10 19:58:20 EDT 2025 Mon Jul 21 05:59:08 EDT 2025 Thu Apr 24 23:01:32 EDT 2025 Sun Jul 06 05:04:06 EDT 2025 Wed Jan 22 17:15:37 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | anti‐IL23 biologics difficult‐to‐treat area guselkumab psoriasis real‐world data |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3600-118e9ad8e963fcd4786a7f28f1e14a4eb85ce9291477446c5d61bb9fc7cbedb03 |
| Notes | Funding source: None. Conflict of interest: N. Rompoti: Honoraria for lectures from AbbVie, Genesis Pharma, Janssen, LEO, Lilly Pharmaserve, Novartis, UCB, and support for scientific congress attendance from AbbVie, Janssen, LEO, Lilly Pharmaserve, Novartis, UCB. T. Vergou: Honoraria for lectures from AbbVie, Genesis Pharma, Janssen, LEO, Lilly Pharmaserve, Novartis, UCB. I. Stefanaki: Honoraria from AbbVie, Genesis, Janssen, LEO Pharma, and Novartis. C. Vavouli: Honoraria for advisory boards from LEO Pharma, Galenica, honoraria for lectures from LEO Pharma, Genesis, Novartis, and support for congress attendance from LEO Pharma, Genesis, Novartis, and Janssen. P. Panagakis: Honoraria for advisory boards, lectures, and travel support to scientific meetings from Abbvie, LEO Pharma, Janssen, Genesis Pharma, Novartis, Mylan, Lilly, Pfizer, and UCB. M. Papoutsaki: Honoraria for advisory boards and lectures from Janssen, LEO Pharma, MSD, Genesis Pharma, Pfizer, Novartis, AbbVie, UCB, and support as investigator in clinical studies from AbbVie, Novartis, LEO Pharma, Janssen. M. Politou: Honoraria for advisory boards from AbbVie, Novartis, Genesis, and LEO Pharma, honoraria for lectures from AbbVie, Janssen, Novartis, Genesis, UCB, and LEO Pharma. V. Chasapi: Honoraria for lectures and support for traveling to scientific meetings from Abbvie, Genesis Pharma, Janssen, LEO Pharma, and Novartis. A. Stratigos: Honoraria for advisory boards, lectures, and support for international congress attendance from Bristol‐Myers Squibb, Novartis, Merck Sharp & Dohme, Sanofi, and research support from Hoffmann‐La Roche. E. Nicolaidou: Honoraria for the advisory board, lectures, and support for scientific meeting attendance from Janssen, LEO Pharma, Novartis, UCB, Lilly Pharmaserve, Gelgene/Genesis Pharma, Galenica, Amgen. A. Befon, F. Kousta, E. Lazou, M. Zaimi, I‐A. Koumprentziotis declare no conflicts of interest. content type line 23 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 |
| ORCID | 0000-0002-9326-6726 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ijd.17400 |
| PMID | 39051109 |
| PQID | 3084773340 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_3084773340 pubmed_primary_39051109 crossref_citationtrail_10_1111_ijd_17400 crossref_primary_10_1111_ijd_17400 wiley_primary_10_1111_ijd_17400_IJD17400 |
| PublicationCentury | 2000 |
| PublicationDate | October 2024 2024-10-00 2024-Oct 20241001 |
| PublicationDateYYYYMMDD | 2024-10-01 |
| PublicationDate_xml | – month: 10 year: 2024 text: October 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | International journal of dermatology |
| PublicationTitleAlternate | Int J Dermatol |
| PublicationYear | 2024 |
| References | 2023 2023; 13 2021; 185 2020; 33 2023; 23 e_1_2_3_2_1 e_1_2_3_6_1 e_1_2_3_5_1 e_1_2_3_4_1 e_1_2_3_3_1 |
| References_xml | – volume: 185 start-page: 1146 year: 2021 end-page: 1159 article-title: Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2 publication-title: Br J Dermatol – volume: 23 start-page: 371 issue: 4 year: 2023 end-page: 381 article-title: Guselkumab for treatment of moderate‐to‐severe plaque psoriasis: real‐life effectiveness and drug‐survival for up to 148 weeks publication-title: Expert Opin Biol Ther – volume: 33 issue: 6 year: 2020 article-title: Real‐life experience of guselkumab in patients with psoriasis publication-title: Dermatol Ther – volume: 13 start-page: 787 issue: 3 year: 2023 end-page: 801 article-title: Long‐term efficacy, safety, and drug survival of guselkumab in patients with psoriasis: real‐world data from the Czech Republic BIOREP Registry publication-title: Dermatol Ther (Heidelb) – year: 2023 article-title: Effectiveness, safety and quality‐of‐life effects of guselkumab and ustekinumab in patients with psoriasis: week 104 results from the non‐interventional, prospective, German multicentre PERSIST study publication-title: J Eur Acad Dermatol Venereol – ident: e_1_2_3_2_1 doi: 10.1111/bjd.20568 – ident: e_1_2_3_6_1 doi: 10.1080/14712598.2023.2194485 – ident: e_1_2_3_4_1 doi: 10.1111/jdv.19296 – ident: e_1_2_3_3_1 doi: 10.1111/dth.13964 – ident: e_1_2_3_5_1 doi: 10.1007/s13555‐023‐00893‐4 |
| SSID | ssj0013214 |
| Score | 2.4205017 |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e255 |
| SubjectTerms | anti‐IL23 biologics difficult‐to‐treat area guselkumab psoriasis real‐world data |
| Title | Real‐world effectiveness and drug survival of guselkumab over a period of 3 years in moderate‐to‐severe plaque psoriasis, including difficult‐to‐treat areas |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fijd.17400 https://www.ncbi.nlm.nih.gov/pubmed/39051109 https://www.proquest.com/docview/3084773340 |
| Volume | 63 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0011-9059 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1365-4632 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0013214 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQh6qXPqAPKKCh6qGHBsVr56WeEBRRJHpAReJQKfITLSzJarM5tCeu3Poz-rv4JZ1xkhX0IVW9RJEythx7xvPZM_7M2BvBTZxYGgEtTCRNrCKNbj-yLlOFt-jUOB0UPv6UHp7Ko7PkbIm9H87CdPwQiw03sowwX5OBK93cMfLxhaVsnJjW61wkIUR7MroTQeh4vWkLsEAM0bMKURbPouR9X_QbwLyPV4PDOXjMvgxN7fJMLnfaud4x335hcfzPf3nCHvVAFHY7zXnKlly1wh4c96H2VfbjBCHk7fX3QKkKXdpHPzOCqizYWXsOTYszDeoq1B7O28ZNLtsrpYHSQkEBkSjXlr6J2-ubr2hTDYwroMt3iKACK5_X-EDf7GYOphOFHQPTpkabaMbNO5Q1k5Z8K9A1LoEkZCgT8uNBUUb9M3Z68OHz3mHUX-sQGYHwKsIljSuUxUcqvLEyy1OV-VHuueNSSafzxDhEbVwiNJWpSWzKtS68yYx2VsfiOVuu6sq9ZBAb7_jIYwUFFkSVQ_CqCdNKxV3u8zX2dhjg0vSc53T1xqQc1j7Y82Xo-TX2eiE67Yg-_iS0PWhJiWZIsRVVubptShGjm8-EkCjzolOfRTWCONB4XGBrghL8vf7y49F-eFn_d9FX7OEIgVaXYLjBluez1m0iUJrrrWARPwE9fhd6 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgGX8i7lOSAOHEgVr715SFwQpdqWbg9VK_WCIj-rpdtktdkc4NQrN34Gv6u_hBknWbU8JMQlipSx5dgzns-e8WfGXglu4qGlEdDCRNLEKtLo9iPrUpV7i06N00Hh8X4yOpK7x8PjFfa2PwvT8kMsN9zIMsJ8TQZOG9KXrHzy2VI6TowL9msUnyOz3DoYXIohtMzetAmYI4roeIUoj2dZ9Ko3-g1iXkWsweVs32Kf-sa2mSanm81Cb5qvv_A4_u_f3GZrHRaFd63y3GErrrzLro-7aPs99uMAUeTF-ffAqgpt5kc3OYIqLdh5cwJ1g5MNqitUHk6a2k1PmzOlgTJDQQHxKFeWvomL829f0KxqmJRA9-8QRwVWvqjwge7ZzR3Mpgp7BmZ1hWZRT-o3KGumDblXoJtcAk9IXyakyIOipPr77Gj7w-H7UdTd7BAZgQgrwlWNy5XFRyK8sTLNEpX6Qea541JJp7OhcQjcuER0KhMztAnXOvcmNdpZHYsHbLWsSveQQWy84wOPFeRYELUO8asmWCsVd5nPNtjrfoQL09Ge0-0b06Jf_mDPF6HnN9jLpeis5fr4k9CLXk0KtEQKr6jSVU1diBg9fSqERJn1Vn-W1QiiQeNxjq0JWvD3-oud3a3w8ujfRZ-zG6PD8V6xt7P_8TG7OUDc1eYbPmGri3njniJuWuhnwTx-AoNDG5Y |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVqq4QHm35TEgDhxIFa-9eagnRFm1hVaoolIPSJGf1dIlWW02Bzj1yq0_g9_VX8KMk6xaHhLiEkXK2HLsGc839vgzYy8EN_HQ0ghoYSJpYhVpdPuRdanKvUWnxumg8MFhsnss90-GJ0tsuz8L0_JDLBbcyDLCfE0GPrX-ipGPP1vKxokxXl-RCUZXhIiOBle2EFpib1oDzBFEdLRClMazKHrdGf2GMK8D1uBxRrfYp76tbaLJ2VYz11vm2y80jv_5M2vsZodE4XWrOrfZkivvsNWDbq_9LvtxhBjy8vwicKpCm_fRTY2gSgt21pxC3eBUg8oKlYfTpnaTs-aL0kB5oaCAWJQrS9_E5fn3r2hUNYxLoNt3iKECK59X-EDn7GYOphOFHQPTukKjqMf1K5Q1k4acK9A9LoElpC8TEuRBUUr9PXY8evvxzW7U3esQGYH4KsKYxuXK4iMR3liZZolK_SDz3HGppNPZ0DiEbVwiNpWJGdqEa517kxrtrI7FfbZcVqV7yCA23vGBxwpyLIg6h-hVE6iVirvMZ-vsZT_AhelIz-nujUnRBz_Y80Xo-XX2fCE6bZk-_iT0rNeSAu2QNldU6aqmLkSMfj4VQqLMg1Z9FtUIIkHjcY6tCUrw9_qLvf2d8LLx76JP2eqHnVHxfu_w3Sa7MUDQ1SYbPmLL81njHiNomusnwTh-AjfzGkU |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real-world+effectiveness+and+drug+survival+of+guselkumab+over+a+period+of+3%E2%80%89years+in+moderate-to-severe+plaque+psoriasis%2C+including+difficult-to-treat+areas&rft.jtitle=International+journal+of+dermatology&rft.au=Rompoti%2C+Natalia&rft.au=Vergou%2C+Theognosia&rft.au=Stefanaki%2C+Irene&rft.au=Vavouli%2C+Charitomeni&rft.date=2024-10-01&rft.eissn=1365-4632&rft.volume=63&rft.issue=10&rft.spage=e255&rft_id=info:doi/10.1111%2Fijd.17400&rft_id=info%3Apmid%2F39051109&rft.externalDocID=39051109 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0011-9059&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0011-9059&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0011-9059&client=summon |